Published in Antiviral Res on July 01, 1988
cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. Proc Natl Acad Sci U S A (1989) 3.09
Antibodies that block rhinovirus attachment map to domain 1 of the major group receptor. J Virol (1990) 1.17
Host immune responses to rhinovirus: mechanisms in asthma. J Allergy Clin Immunol (2008) 1.14
Virus receptors: implications for pathogenesis and the design of antiviral agents. Clin Microbiol Rev (1995) 1.07
Intranasal antibody prophylaxis for protection against viral disease. Clin Microbiol Rev (1999) 1.00
Strategies for the identification of icosahedral virus receptors. J Clin Invest (1992) 0.91
Prevention of human rhinovirus infection by multivalent fab molecules directed against ICAM-1. Antimicrob Agents Chemother (2003) 0.80
Biochemical prevention and treatment of viral infections - a new paradigm in medicine for infectious diseases. Virol J (2004) 0.78
Adaptation of an ICAM-1-tropic enterovirus to the mouse respiratory tract. J Virol (2011) 0.78
The infectious march: the complex interaction between microbes and the immune system in asthma. Immunol Allergy Clin North Am (2010) 0.77
Social ties and susceptibility to the common cold. JAMA (1997) 7.08
A unique RNA species involved in initiation of vesicular stomatitis virus RNA transcription in vitro. Cell (1976) 3.82
Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J Virol (1986) 3.59
Many rhinovirus serotypes share the same cellular receptor. J Virol (1984) 3.59
Vesicular stomatitis virus: mode of transcription. J Gen Virol (1977) 3.53
Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis (1975) 3.33
In vitro synthesis of an infectious RNA from cDNA clones of human rhinovirus type 14. J Virol (1985) 3.19
Molecular cloning and complete sequence determination of RNA genome of human rhinovirus type 14. Proc Natl Acad Sci U S A (1985) 3.17
cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. Proc Natl Acad Sci U S A (1989) 3.09
Complete nucleotide sequence of the leader RNA synthesized in vitro by vesicular stomatitis virus. Cell (1978) 3.06
Zoster sine herpete, a clinical variant. Ann Neurol (1994) 2.84
Transmission of rhinovirus colds by self-inoculation. N Engl J Med (1973) 2.80
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine. Antimicrob Agents Chemother (2004) 2.67
A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann Intern Med (1996) 2.66
De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus. J Virol (2000) 2.65
The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth. J Virol (1994) 2.61
Sinusitis of the maxillary antrum. N Engl J Med (1975) 2.57
Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.54
Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses. J Virol (1986) 2.54
The major and minor group receptor families contain all but one human rhinovirus serotype. Virology (1991) 2.50
Types of stressors that increase susceptibility to the common cold in healthy adults. Health Psychol (1998) 2.47
Hand-to-hand transmission of rhinovirus colds. Ann Intern Med (1978) 2.46
Rhinovirus infections in an industrial population. I. The occurrence of illness. N Engl J Med (1966) 2.27
Temperature-sensitive mutants of influenza A virus. XII. Safety, antigenicity, transmissibility, and efficacy of influenza A/Udorn/72-ts-1[E] recombinant viruses in human adults. J Infect Dis (1976) 2.12
A collaborative report: rhinoviruses--extension of the numbering system from 89 to 100. Virology (1987) 2.10
Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J Infect Dis (1975) 2.05
Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor. J Virol (1995) 2.05
Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro. J Biol Chem (1990) 1.99
Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults. Antimicrob Agents Chemother (1981) 1.99
Methods to improve detection of pneumococci in respiratory secretions. J Clin Microbiol (1975) 1.94
Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus. Antimicrob Agents Chemother (1997) 1.94
Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors. Proc Natl Acad Sci U S A (1996) 1.93
Identification of the herpes simplex virus-1 protease cleavage sites by direct sequence analysis of autoproteolytic cleavage products. J Biol Chem (1993) 1.92
Intervening polyadenylate sequences in RNA transcripts of vesicular stomatitis virus. Cell (1978) 1.92
In vitro susceptibility studies with josamycin and erythromycin. Antimicrob Agents Chemother (1976) 1.89
Interferon induction of fibroblast proteins with guanylate binding activity. J Biol Chem (1983) 1.87
Effect of inhalation of hot humidified air on experimental rhinovirus infection. JAMA (1994) 1.87
Mapping and initiation studies on the leader RNA of vesicular stomatitis virus. Virology (1977) 1.78
Alteration of cerebrospinal fluid findings by partial treatment of bacterial meningitis. J Pediatr (1973) 1.77
Induction of unique mRNAs by human interferons. J Biol Chem (1982) 1.76
Isolation of a receptor protein involved in attachment of human rhinoviruses. J Virol (1986) 1.68
Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade. J Virol (1986) 1.68
Rhinoviruses. Yale J Biol Med (1975) 1.66
Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. Rev Infect Dis (1983) 1.64
Rapid diagnosis of lymphocytic meningitis by frequency-pulsed electron capture gas-liquid chromatography: differentiation of tuberculous, cryptococcal, and viral meningitis. J Clin Microbiol (1977) 1.63
Coronavirus infections in military recruits. Three-year study with coronavirus strains OC43 and 229E. Am Rev Respir Dis (1974) 1.62
In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632. Antimicrob Agents Chemother (2000) 1.59
Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. N Engl J Med (1986) 1.56
A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge. Am J Epidemiol (1971) 1.54
Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis (1979) 1.52
In vitro synthesis of messenger RNA by a defective interfering particle of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1977) 1.51
Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother (1987) 1.49
Accuracy of Gram's stain in identifying pneumococci in sputum. JAMA (1978) 1.48
Interruption of experimental rhinovirus transmission. J Infect Dis (1980) 1.47
Hospital-acquired infections. I. Surveillance in a university hospital. Am J Epidemiol (1976) 1.47
Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection. Antimicrob Agents Chemother (1998) 1.45
Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro. Antimicrob Agents Chemother (2002) 1.45
Micro-neutralization test for identification of rhinovirus serotypes. Proc Soc Exp Biol Med (1966) 1.44
Kinins are generated during experimental rhinovirus colds. J Infect Dis (1988) 1.44
Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors. Antimicrob Agents Chemother (1992) 1.39
Cleavage of small peptides in vitro by human rhinovirus 14 3C protease expressed in Escherichia coli. J Virol (1989) 1.38
New human adenovirus isolated from a renal transplant recipient: description and characterization of candiate adenovirus type 34. J Clin Microbiol (1975) 1.37
In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir. Antimicrob Agents Chemother (1998) 1.36
Human-murine chimeras of ICAM-1 identify amino acid residues critical for rhinovirus and antibody binding. J Virol (1991) 1.36
Cell surface receptors for picornaviruses. Bioessays (1986) 1.35
Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response. JAMA (1967) 1.33
Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA (1986) 1.30
Etiology and antimicrobial treatment of acute sinusitis. Ann Otol Rhinol Laryngol Suppl (1981) 1.30
Intranasal interferon alpha 2 for prevention of rhinovirus infection and illness. J Infect Dis (1983) 1.30
Rhinovirus inhibition by 3-substituted triazinoindoles. Proc Soc Exp Biol Med (1970) 1.29
Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus. Antimicrob Agents Chemother (1999) 1.27
Activity of 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile (MDL-860) against picornaviruses in vitro. Antimicrob Agents Chemother (1982) 1.27
Biochemical studies on capped RNA primers identify a class of oligonucleotide inhibitors of the influenza virus RNA polymerase. Proc Natl Acad Sci U S A (1994) 1.27
BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agents. Antimicrob Agents Chemother (2000) 1.26
Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds. Antimicrob Agents Chemother (1988) 1.25
Methylation of messenger RNA of Newcastle disease virus in vitro by a virion-associated enzyme. Proc Natl Acad Sci U S A (1975) 1.24
Coronavirus infections in working adults. Eight-year study with 229 E and OC 43. Am Rev Respir Dis (1972) 1.23
Swine-influenza infection in civilians. Report of two cases. N Engl J Med (1976) 1.23
Diagnosis of pneumococcal pneumonia by antigen detection in sputum. J Clin Microbiol (1978) 1.22
Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection. Antimicrob Agents Chemother (1982) 1.22
Rapid identification of pneumococci. Gram stain vs. the quellung reaction. N Engl J Med (1973) 1.21
Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization. J Infect Dis (1995) 1.21
Antigenic conservation and divergence between the viral-specific proteins of poliovirus type 1 and various picornaviruses. Virology (1985) 1.20
Nucleotide sequence of the leader RNA of the New Jersey serotype of vesicular stomatitis virus. Nucleic Acids Res (1978) 1.18
Transmission of experimental rhinovirus infection by contaminated surfaces. Am J Epidemiol (1982) 1.18
Alterations of the eustachian tube, middle ear, and nose in rhinovirus infection. Arch Otolaryngol Head Neck Surg (1989) 1.18
Identification of the serine residue at the active site of the herpes simplex virus type 1 protease. J Biol Chem (1994) 1.17
Antibodies that block rhinovirus attachment map to domain 1 of the major group receptor. J Virol (1990) 1.17
Rhinovirus infections in an industrial population. IV. Infections within families of employees during two fall peaks of respiratory illness. Am J Epidemiol (1969) 1.17
Respiratory syncytial virus stimulation of vascular endothelial cell growth Factor/Vascular permeability factor. Am J Respir Cell Mol Biol (2000) 1.17
State and trait negative affect as predictors of objective and subjective symptoms of respiratory viral infections. J Pers Soc Psychol (1995) 1.17
Viral aggregation resulting in the failure to correctly identify an unknown rhinovirus. Appl Microbiol (1970) 1.16
Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis (1994) 1.15
Chimeric picornavirus polyproteins demonstrate a common 3C proteinase substrate specificity. J Virol (1989) 1.15
Isolation of a transcriptive complex from Newcastle disease virions. J Virol (1976) 1.15
Characterization of vesicular stomatitis virus mRNA species synthesized in vitro. J Virol (1977) 1.14
Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol Suppl (1984) 1.14
Inactivation of rhinovirus on human fingers by virucidal activity of glutaric acid. Antimicrob Agents Chemother (1984) 1.13
Relation between naturally acquired immunity and infectivity of two rhinoviruses in volunteers. J Infect Dis (1972) 1.13